Unmet needs in obesity management

Ritten, Angela; LaManna, Jacqueline B.

doi:10.1002/2327-6924.12507

Cited by 15 publications

(12 citation statements)

References 62 publications

(85 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It appears as a self-fulfilling prophecy. This is in accordance with other studies that examined weightrelated challenges dating back to adolescence (Malterud & Ulriksen, 2010;Ritten & LaManna, 2017). Hofmann (2016) found that food and eating are phenomena with strong cultural bearings and that they are profoundly private.…”

Section: To Be Alienated As a Human Beingsupporting

confidence: 91%

Living with obesity — existential experiences

Ueland

Furnes

Dysvik

et al. 2019

International Journal of Qualitative Studies on Health and Well

View full text Add to dashboard Cite

Aims and objectives : The aim was to gain in-depth understanding about individuals’ existential experiences of living with obesity. Background : People living with obesity face great vulnerability and existential challenges. The different treatments offered do not seem to meet the individual needs of persons with obesity. A deeper understanding of existential experiences from an individual perspective is needed to individualize treatment. Design : An exploratory phenomenological–hermeneutical design was used to gain a greater understanding of the existential experiences involved in living with obesity. Methods : The participants represented a convenient sample. 18 qualitative interviews were conducted and subjected to phenomenological–hermeneutical analysis. Results : Four themes emerged: shaped by childhood; captured by food; depressed by the culture ; and judged by oneself . Conclusions : The burden of being obese can be experienced as being objectified and alienated as a human being. We need to turn towards a life-world perspective, seeing each human being as a living body to overcome objectification and alienation, and then move them towards becoming subjects in their own lives, through giving space for self-love . Health care workers need to assist persons living with obesity to reduce objectification and alienation. It is important to develop intervention that has an individual, holistic approach.

show abstract

Section: To Be Alienated As a Human Beingsupporting

confidence: 91%

Living with obesity — existential experiences

Ueland

Furnes

Dysvik

et al. 2019

International Journal of Qualitative Studies on Health and Well

View full text Add to dashboard Cite

show abstract

“…Our results showed that overweight or obese patients were at risk of deteriorating the satisfaction of needs. High levels of unmet needs in obese patients were also reported in previous studies [ 44 ]. It is known that obesity is a causative factor in a diverse range of comorbid diseases.…”

Section: Discussionsupporting

confidence: 74%

Indicators of an Integrated Home Care Model Shaped by the Needs of Patients Discharged from the Emergency Department

Szwamel

Kurpas

2020

International Journal of Integrated Care

View full text Add to dashboard Cite

Introduction: Developing community care models aims to satisfy the needs of patients' in-home care comprehensively. This is crucial to decrease adverse events and prevent rehospitalization. Methods: A cross-sectional study was conducted among 200 emergency department patients (EDPs) and 200 general practice patients (GPPs). The modified version of the Camberwell Assessment of Need Short Appraisal Schedule (CANSAS), the Health Behavior Inventory (HBI), the Generalized Self-Efficacy Scale (GSES), the Patient Satisfaction Questionnaire (PSQ), and the Multidimensional Health Locus of Control Scale (MHLCS) were used. Results: The study indicated the higher level of unmet needs in EDPs than in the population of GPPs (p = 0.008). The unmet needs increased risk of hospitalization in both groups: OR = 0.28 [95%CI 0.15-0.52] for EDP and OR = 0.33, [95%CI 0.17-0.62] for GPPs groups. We also found a significant relationship between the low levels of needs satisfaction and social-demographic variables, including health profile and the level of health behavior, generalized self-efficacy, health locus of controls, and healthcare measures in general practice. Discussion and Conclusion: We suggest that the identified factors should be included into the integrated community care model to advance satisfaction of patients' needs, especially in patients discharged from an emergency department.

show abstract

“…Obesity is a chronic, relapsing, progressive disease (1) with a multifactorial origin, including genetic, metabolic, behavioral, sociocultural, and environmental factors (2,3). The clinical complications of obesity include cardiovascular diseases (CVD; e.g., ischemic heart disease, heart failure), metabolic diseases (type 2 diabetes [T2D]), mechanical dysfunction (musculoskeletal disorders [e.g., osteoarthritis]), sleep apnea, and malignancy (4‐7). Around 13% to 19.5% of adults globally have obesity, and the prevalence of obesity is predicted to continue to rise (5,8).…”

Section: Introductionmentioning

confidence: 99%

Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5

Kushner

Calanna

Davies

et al. 2020

Obesity

174

161

View full text Add to dashboard Cite

Objective The obesity epidemic is a public health concern, warranting further research into pharmacological treatments for weight management (WM) as an adjunct to lifestyle interventions. The Semaglutide Treatment Effect in People with obesity (STEP) program aims to investigate the effect of semaglutide versus placebo on weight loss, safety, and tolerability in adults with obesity or overweight. Methods Across five phase 3 trials (NCT03548935, WM; NCT03552757, WM in type 2 diabetes; NCT03611582, WM with intensive behavioral therapy; NCT03548987, sustained WM; and NCT03693430, long‐term WM), ~5,000 participants are being randomly assigned to receive semaglutide 2.4 mg once weekly subcutaneously versus placebo. Results will be available in 2020/2021. For all trials, the primary end point is change from baseline to end of treatment in body weight. Results Participants have a mean age of 46.2 to 55.3 years, are mostly female (mean: 74.1%‐81.0%), and have a mean BMI of 35.7 to 38.5 kg/m2 and a mean waist circumference of 113.0 to 115.7 cm. Conclusions The STEP program evaluates the efficacy and safety of semaglutide 2.4 mg subcutaneously once weekly in a broad population. The trials will provide insights on WM in people with obesity with and without type 2 diabetes and on long‐term follow‐up.

show abstract

Unmet needs in obesity management

Cited by 15 publications

References 62 publications

Living with obesity — existential experiences

Living with obesity — existential experiences

Indicators of an Integrated Home Care Model Shaped by the Needs of Patients Discharged from the Emergency Department

Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5

Contact Info

Product

Resources

About